Pfizer Inc. closed $4.65 short of its 52-week high ($31.54), which the company reached on July 30th.

PFE's strong economic moat is threatened by upcoming patent expirations, but its oncology segment shows promising growth ...

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or ...

The OLED T lets you switch between its mind-boggling transparent mode, where you can clearly see whatever’s behind the OLED panel, and an opaque mode that eliminates distractions when enjoying ...

Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 ...

The 2024 regular season is coming down to the wire. With the Christmas holiday on the horizon, teams are continuing to jockey for playoff position, heating things to a fever pitch. We've also ...

If you have $60,000 burning a hole in your pocket, you can now get your hands on the LG Signature OLED T, a fully wireless, transparent 77-inch OLED TV. The TV maker showed it off at CES earlier ...

Funded by Pfizer, this research addresses the challenges of aging populations and the growing demand for caregiving solutions, offering valuable insights into user-centric approaches to assistive ...

Beata Zawrzel / NurPhoto via Getty Images Pfizer on Tuesday affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.

Sabahat Bokhari, a Rutgers professor of medicine and an amyloidosis expert, will direct a fellowship at Robert Wood Johnson University Hospital Pfizer has awarded $80,000 to Rutgers Robert Wood ...

Pfizer (PFE, Financial) has said it expects its 2025 revenue and earnings to match market consensus, even as it predicts such a redesign of federal drug benefits will hit it with a $1 billion hit.

Pfizer forecast 2025 revenue and earnings in ... and make sure their analysis is clear and in no way misleading or deceptive. To further protect the integrity of our editorial content, we keep ...